A case in point: it turns out that only about half of the new prescription medications pushed onto the market over the last decade had the proper data together for the U.S. Food and Drug Administration - yet the FDA approved them anyhow.
The researchers found that only about half of 197 eligible approved NMEs between 2000 and 2010 had comparative efficacy data available at the time they were approved to be marketed.
Meanwhile, another recent study throws needed light on the limited data behind the safety and effectiveness of some Big Pharma drugs.
The North Dakota supreme court revived the state’s abortion ban on Friday, once again making it...
Cases of infant botulism tied to the ByHeart infant formula recall have nearly tripled across 15...
A federal judge officially approved drug maker Purdue Pharma’s latest deal to settle thousands of lawsuits...
